Combinations of peptides and peptides for use in Immunotherapy against non Hodgkin's lymphoma (NHL) and other types of cancer

摘要

The present Invention relates to Peptides, Proteins, Nucleic acids and Cells for use in immunotherapeutic methods.In particular, this application relates to Immunotherapy against cancer.Claim 1: Peptide comprising an Amino Acid Sequence selected from the group consisting of SEQ ID no. 1 to the SEQ ID no. 311Sequences and variants thereof that are at least a 88% homologous to the SEQ ID no. 1 to the SEQ ID no. 311And in that Variant binds to one or more Molecules of the major histocompatibility complex (MHC) and / or induces t-cell Cross reaction with the Peptide Variant and a Salt farmacu00e9uti;Cally acceptable, in that this Peptide is a polypeptide.